Macrophages and monocytes in liver cirrhosis – beyond immunity
von Prof. Dr. med. Christine Bernsmeier, University of Basel, Department of Biomedicine, Basel, Switzerland
Transjugular intrahepatic portosystemic shunt – emerging indications and prognostic impact in decompensated liver cirrhosis
von Prof. Dr. med. Virginia Hernández-Gea, Liver Unit, Hospital Clinic-IDIBAPS Barcelona, Spain
Gut barrier impairment in ALD pathogenesis
Professor Shilpa Chokshi, the Roger Williams Institute of Hepatology, London, UK
Targeting the gut microbiota to treat ALD
Professor Peter Stärkel, Institute of Experimental and Clinical Research Université Catholique de Louvain, Belgium
The Role of Artificial Intelligence in HCC as a Tool for Diagnosis and Prognosis
Professor Dr. med. Julien Calderaro, Henri Mondor University Hospital, Department of Pathology, Creteil, France
Tailored Therapy in advanced Hepatocellular Carcinoma – current status and future directions
Professor Dr. med. Massimo Alberto lavarone, Policlinico di Milano, Gastroenterology and Hepatology, Milano, Italy
Cookie und Datenfreigabe Einstellung
Auf unserer Website verwenden wir Cookies und Anwendungen von Drittanbietern, um einen optimalen Online-Service zu gewährleisten. Um Ihre Privatsphäre zu schützen können Sie diese Anwendungen hier kontrollieren und verwalten.
